Rolf Barth to Cell Line, Tumor
This is a "connection" page, showing publications Rolf Barth has written about Cell Line, Tumor.
Connection Strength
0.030
-
Inhibiting CARD11 translation during BCR activation by targeting the eIF4A RNA helicase. Blood. 2014 Dec 11; 124(25):3758-67.
Score: 0.020
-
Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4. Clin Cancer Res. 2005 Jan 01; 11(1):341-50.
Score: 0.010